These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28160943)

  • 21. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
    Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
    Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, β-glucuronidase inhibition and molecular docking studies of hybrid bisindole-thiosemicarbazides analogs.
    Taha M; Ismail NH; Imran S; Rahim F; Wadood A; Khan H; Ullah H; Salar U; Khan KM
    Bioorg Chem; 2016 Oct; 68():56-63. PubMed ID: 27454618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 2-Aminopyrimidine Derivatives and Their Evaluation as
    Iqbal S; Shaikh NN; Khan KM; Kiran S; Naz S; Ul-Haq Z; Perveen S; Choudhary MI
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of indole analogs as potent β-glucuronidase inhibitors.
    Baharudin MS; Taha M; Imran S; Ismail NH; Rahim F; Javid MT; Khan KM; Ali M
    Bioorg Chem; 2017 Jun; 72():323-332. PubMed ID: 28505547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis: Small library of hybrid scaffolds of benzothiazole having hydrazone and evaluation of their β-glucuronidase activity.
    Taha M; Arbin M; Ahmat N; Imran S; Rahim F
    Bioorg Chem; 2018 Apr; 77():47-55. PubMed ID: 29331764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Oxo-1,2,3,4-tetrahydropyrimidines Ethyl Esters as Potent β- Glucuronidase Inhibitors: One-pot Synthesis, In vitro and In silico Studies.
    Iqbal S; Shaikh NN; Khan KM; Naz S; Ul-Haq Z; Perveen S; Choudhary MI
    Med Chem; 2018; 14(8):818-830. PubMed ID: 29793412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
    Bajaj S; Kumar MS; Tinwala H; Yc M
    Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors.
    Taha M; Ismail NH; Imran S; Selvaraj M; Rashwan H; Farhanah FU; Rahim F; Kesavanarayanan KS; Ali M
    Bioorg Chem; 2015 Aug; 61():36-44. PubMed ID: 26073618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, SAR elucidations and molecular docking study of newly designed isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase.
    Javid MT; Rahim F; Taha M; Nawaz M; Wadood A; Ali M; Mosaddik A; Shah SAA; Farooq RK
    Bioorg Chem; 2018 Sep; 79():323-333. PubMed ID: 29803079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel N-(1,3-thiazol-2-yl)benzamide clubbed oxadiazole scaffolds: Urease inhibition, Lipinski rule and molecular docking analyses.
    Athar Abbasi M; Raza H; Aziz-Ur-Rehman ; Zahra Siddiqui S; Adnan Ali Shah S; Hassan M; Seo SY
    Bioorg Chem; 2019 Mar; 83():63-75. PubMed ID: 30342387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flurbiprofen derivatives as novel α-amylase inhibitors: Biology-oriented drug synthesis (BIODS), in vitro, and in silico evaluation.
    Khan M; Alam A; Khan KM; Salar U; Chigurupati S; Wadood A; Ali F; Mohammad JI; Riaz M; Perveen S
    Bioorg Chem; 2018 Dec; 81():157-167. PubMed ID: 30125730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study.
    Taha M; Irshad M; Imran S; Chigurupati S; Selvaraj M; Rahim F; Ismail NH; Nawaz F; Khan KM
    Eur J Med Chem; 2017 Dec; 141():530-537. PubMed ID: 29102178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.
    He H; Wang W; Zhou Y; Xia Q; Ren Y; Feng J; Peng H; He H; Feng L
    Bioorg Med Chem; 2016 Apr; 24(8):1879-88. PubMed ID: 26972920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
    Yu W; Ping Cheng L; Pang W; Ling Guo L
    Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
    Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
    Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.
    Khan KM; Saad SM; Shaikh NN; Hussain S; Fakhri MI; Perveen S; Taha M; Choudhary MI
    Bioorg Med Chem; 2014 Jul; 22(13):3449-54. PubMed ID: 24844756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bis-1,3,4-Oxadiazole Derivatives as Novel and Potential Urease Inhibitors; Synthesis, In Vitro, and In Silico Studies.
    Shah S; Khan M; Ali M; Wadood A; Ur Rehman A; Shah Z; Yousaf M; Salar U; Khan KM
    Med Chem; 2022; 18(7):820-830. PubMed ID: 35232342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
    Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
    Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
    Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.